Practice Areas & Industries: Greenberg Traurig, LLP


Group Profile Lawyers in this Group Offices Locations for this Group

Practice/Industry Group Overview

Greenberg Traurig’s multidisciplinary legal team focuses on guiding emerging technology companies through all the stages of their development, from initial business formation through angel or venture capital financing to initial public offerings and mergers and acquisitions.  We understand the needs of entrepreneurs, as well as the challenges they face. Drawing on the firm’s broad platform, we offer clients a streamlined approach to meeting their diverse legal needs – a single team that can scale up our services as our clients’ businesses grow. We regularly advise clients on a host of pressing legal issues, from IP protection and software/IT matters through labor and employment, compensation and tax issues.

Practical Legal Services for Emerging Technology Companies

  • Counsel clients on start-up and organizational matters, including entity selection, corporate formation, operating agreements, executive and employee compensation, stock ownership / option plans and governance strategies
  • Advise on joint ventures, strategic alliances and other business relationships
  • Advise entrepreneurs and emerging companies on developing strategies to attract and secure financing from angels, venture capital firms and private equity funds
  • Facilitate introductions to potential financing sources by drawing on GT’s broad network of working relationships in the private equity and venture capital arena
  • Structure equity ownership and compensation arrangements in a tax-efficient manner for entrepreneurs
  • Develop patent portfolio strategies
  • Counsel clients on the development, protection and enforcement of their patents and trademarks, as well as partnering, technology licensing and acquisition opportunities
  • Help companies address IT needs, including outsourcing and software-related matters
  • Advise clients on labor and employment issues, employee benefits policies and related issues
  • Provide litigation and dispute resolution counseling and services, including proactive advice on minimizing the risk of litigation, as needed
  • Help clients plan for and implement financing and exit strategies, from private placements to initial public offerings and mergers and acquisitions
  • Represent both emerging and established companies in their efforts to compete with incumbent operators, domestically and internationally

A Business-minded approach to advising our clients

  • Provide sophisticated legal counsel based on our many years of experience helping clients form, finance and grow their companies
  • Support our clients in the markets where they do business, with competitive rates in all of the local markets where GT has offices
  • Offer clients a streamlined approach to handling their legal needs – a single point of contact to efficiently access a multidisciplinary platform of legal services, all provided by a single firm
  • Provide clients with access to the hubs of innovation for emerging technology, as well as other key commercial and financial centers, via GT offices in Boston, New York, Silicon Valley, San Francisco, Phoenix, Austin and other markets throughout the United States

Industry Experience

  • Alternative energy (biofuels)
  • Biotechnology
  • Clean technology
  • Consumer products
  • Drug discovery
  • Entertainment and media
  • Financial technology
  • Health care
  • Information technology and e-commerce
  • Life sciences
  • Medical devices
  • Mobile devices and internet
  • Nanotechnology
  • Pharmaceuticals
  • Semiconductors
  • Social media
  • Software
  • Stem cells
  • Telecommunications
  • Video gaming
  • Voice recognition
  • Web 2.0

Articles Authored by Lawyers at this office:

Assistant Attorney General Baer Reports on Recent Developments in DOJ Remedies and Enforcement Policies
Gregory J. Casas, November 21, 2013
On September 25th, Bill Baer, Asst. Attorney General in charge of the Antitrust Division of the Department of Justice (DOJ), spoke at the Georgetown Law 7th Annual Global Antitrust Enforcement Symposium on recent developments in the DOJ's enforcement policy. The speech provided practitioners and...

EU Merger Control and Minority Shareholdings: Time to Plug the Enforcement Gap?
Simon Harms,Irving Scher, November 21, 2013
First created in 1989, the European Union (EU) merger control regime has now been around for the better part of a quarter of a century and is a well-established fact of life for businesses involved in large-scale M&A transactions. During that time, the European Commission (the Commission) has...

Final Rules Adopted, Making More Pharmaceutical Patent Transfers Subject to the HSR Act: Increased Review Raises Importance of Valuation
Mary K. Marks, November 21, 2013
On November 6, 2013, the Federal Trade Commission (FTC) in consultation with the U.S. Department of Justice issued final amendments to the premerger notification rules regarding when a transfer of rights to a pharmaceutical patent is reportable under the Hart-Scott-Rodino (HSR) Act. The commission...

New HSR Rules Will Require More Filings for Pharmaceutical Patent Transfers: Increased Review Raises Importance of Valuation
Mary K. Marks, November 11, 2013
Amendments to the Rules under the Hart-Scott-Rodino (HSR) Act have been adopted that will require compliance with the Act’s reporting and waiting period requirements for certain acquisitions of exclusive pharmaceutical patent licenses that historically have not been reportable because the...